期刊文献+

慢性阻塞性肺病急性加重期C反应蛋白检测的临床意义 被引量:18

The clinical significance of C-reactive proteine in acute exacerbation of chronic obstruction pulmonary disease
下载PDF
导出
摘要 目的:研究慢性阻塞性肺病(COPD)患者急性加重期(AECOPD)与缓解期血清C反应蛋白(CRP)水平变化,探讨血清CRP水平对AECOPD患者的诊断意义和临床价值。方法:应用免疫透射比浊法检测43例COPD患者在疾病急性加重期(治疗前)与缓解期(治疗后)的血清CRP水平,同时行血白细胞计数(WBC)、中性粒细胞(N)、红细胞沉降率(ESR)检测及肺功能检查[一秒用力呼出量占预计值百分比(FEV1%)、一秒用力呼出量占肺活量的百分比(FEV1/FVC)]。结果:AECOPD患者CRP阳性率为72.1%,显著高于WBC、N、ESR的阳性发现(P<0.01)。患者急性加重期CRP含量高达(37.61±5.74)mg/L,而缓解期迅速下降至(8.19±3.24)mg/L,较急性加重期显著降低(P<0.01)。AECOPD患者血清CRP与FEV1%、FEV1/FVC的相关性分别为-0.511和-0.644,呈显著负相关,P值均<0.05。结论:AECOPD患者血清CRP水平显著升高,血清CRP检测可作为COPD急性加重的诊断及严重度评估的灵敏指标。 Objective To study the serum C-reactive protein (CRP)level variation in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and stable chronic obstruction pulmonary disease (COPD), and to investigate its diagnostic value and clinical significance. Methods The serum CRP levels of 43 patients with AECOPD at stable and at exacerbation were measured by turbidimetric immunoassay. The data obtained from examinations of white blood cell (WBC), neutrophil(N), erythrosedimentation(ESR), chest X-ray, forced expiratory volume in ls (FEV1) forced exiratory volume in 1s/forced vital capacity (FEV1/FVC) were also collected. The association between the FEV1 or FEV1/FVC and CRP level were analyzed. Results The positive rates of the serum CRP (72.1%) is significantly higher than the other tests (WBC,N,ESR,X-ray) (P 〈0.01). The serum CRP levels of COPD patients at exacerbation [(37.61±5.74 mg/L )were significantly higher than those of the patients at stable (8.19±3.24 mg/L (P〈0.01), which were significantly correlated negatively with FEV1 and FEV1/FVC (r=-0.511 and -0.644, P〈0.05). Conclusions The serum CRP level of AECOPD patients increases significantly and it is a sensitive index in diagnosis of AECOPD and assessment of severity.
作者 赵勉之 周新
出处 《诊断学理论与实践》 2007年第5期406-408,共3页 Journal of Diagnostics Concepts & Practice
关键词 慢性阻塞性肺病 急性加重期 C反应蛋白 Obstructive pulmonary disease Acute exacerbation C-reactive protein
  • 相关文献

参考文献9

  • 1[1]Global Initiative for Chronic Obstructive Pulmonary Disease.Global strategy for the diagnosis,management and prevention of chronic obstructive pulmonary disease[A/OL].[2006].www.goldcopd.com.
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8227
  • 3周新.慢性阻塞性肺疾病急性加重诊疗的若干问题探讨[J].中国实用内科杂志,2006,26(10):1471-1473. 被引量:36
  • 4[4]Volanakis JE.Human C-reactive protein:expression,structure,and function[J].Mol Immunol,2001,38 (2-3):189-197.
  • 5[5]Wedzicha JA,Seemungal TA.COPD exacerbations:defining their cause and prevention[J].Lancet,2007,370(9589):786-796.
  • 6[6]Gan WQ,Man SF,Sin DD.The interactions between cigarette smoking and reduced lung function on systemic inflammation[J].Chest,2005,127(2):558-564.
  • 7[7]Donaldson GC,Seemungal TA,Bhowmik A,et al.Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease[J].Thorax,2002,57(10):847-852.
  • 8[8]Barnes PJ,Chowdhury B,Kharitonov SA,et al.Pulmonary biomarkers in chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,2006,174(1):6-14.
  • 9[9]Perera WR,Hurst JR,Wilkinson TM,et al.Inflammatory changes,recovery and recurrence at COPD exacerbation[J].Eur Respir J,2007,29(3):527-534.

二级参考文献16

  • 1有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 2Anthonisen NR,Manfreda J,Warren CPW,et al.Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease[J].Ann Intern Med,1987,106 (2):196 -204.
  • 3Celli BR,MacNee W,Agusti A,et al.Standards for diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper[J].Eur Respir J,2004,23 (6):932-946.
  • 4Burge S,Wedzicha JA.COPD exacerbations:definitions and classifications[J].Eur Respir J,2003,41 (Suppl):46-53.
  • 5Global Initiative for Chronic Obstructive Pulmonary Disease.Global strategy for the diagnosis,management and prevention of chronic obstructive pulmonary disease,Executive Summary[EB/OL].Available at:www.goldcopd.com.2005.
  • 6Sethi S,Evans N,Grant B,et al.New strains of bacteria and exacerbations of chronic obstructive pulmonary disease[J].N Engl J Med,2002,347:465-471.
  • 7Rogriguez-Roisin R.COPD exacerbations 5:management[J].Thorax,2006,61:535-544.
  • 8Singh JM,Palda VA,Stanbrook MB,et al.Corticosteroid therapy for patients with acute exacerbations of chronic obstructive pulmonary disease:a systematic review[J].Arch Intern Med,2002,162 (12):2527-2536.
  • 9Maltais F,Ostinali J,Bourbeau J,et al.Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease:a randomized controlled trial[J].Am J Respir Crit Care Med,2002,165:698-703.
  • 10Keenan SP,Gregor J,Sibbald WJ,et al.Noninvasive positive pressure ventilation in the setting of severe,acute exacerbations of chronic obstructive pulmonary disease:more effective and less expensive[J].Crit Care Med,2000,28:2094-2102.

共引文献8255

同被引文献70

引证文献18

二级引证文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部